MT695836
Miniopterus fuliginosus isolate N21333 D-loop, partial sequence; mitochondrial.
294
DNA
Miniopterus fuliginosus
N21333
yx49e10.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:265098 3' similar to gb:K00558 TUBULIN ALPHA-1 CHAIN (HUMAN), mRNA sequence.
468
mRNA
Homo sapiens
LV567155
JP 2017029159-A/21333: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
HW856557
JP 2015051004-A/21285: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
LF680554
JP 2016521556-A/21333: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
DL903077
JP 2014205669-A/21333: Method of constructing and screening libraries of peptide structures.
21
PRT
synthetic construct
DD801603
JP 2008525033-A/21333: Group B Streptococcus.
687
PRT
Streptococcus agalactiae
MD753575
JP 2019507579-A/21333: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
MC773443
JP 2018525446-A/21333: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
28
PRT
synthetic construct
DJ150713
JP 2007228956-A/21331: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
HZ526114
JP 2016501039-A/21333: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
FU795814
JP 2009528046-A/21331: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DM722478
JP 2016500250-A/21333: ENGINEERED SECRETED PROTEINS AND METHODS.
120
PRT
Saccharomyces cerevisiae
DJ525133
JP 2010517930-A/21333: Method of constructing and screening libraries of peptide structures.
21
PRT
synthetic construct
DL030347
JP 2005512499-A/21333: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
671
DNA
synthetic construct
PA525817
JP 2022502046-A/8599: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DD547936
JP 2004508801-A/21333: NEISSERIAL ANTIGENIC PEPTIDES.
6
PRT
Neisseria
DL611935
JP 2011092200-A/21333: NEISSERIAL ANTIGENIC PEPTIDES.
6
PRT
Neisseria
LX118949
JP 2017506877-A/21331: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HW186361
JP 2013102767-A/21285: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
PA392056
JP 2021533803-A/21139: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DM758027
JP 2014079248-A/21333: NEISSERIAL ANTIGENIC PEPTIDES.
6
PRT
Neisseria
MC163177
JP 2019500349-A/21333: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
OG750852
JP 2021120380-A/21333: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
MD267466
JP 2020517247-A/21333: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
LF828489
JP 2016528161-A/21322: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
HV877874
JP 2010507387-A/21285: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
PA336981
JP 2021522188-A/21333: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
MC549833
JP 2019525738-A/21333: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
8
PRT
synthetic construct
DM795791
JP 2014068652-A/21333: NEISSERIAL ANTIGENIC PEPTIDES.
6
PRT
Neisseria